These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18656367)

  • 1. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
    Desbois N; Gardette M; Papon J; Labarre P; Maisonial A; Auzeloux P; Lartigue C; Bouchon B; Debiton E; Blache Y; Chavignon O; Teulade JC; Maublant J; Madelmont JC; Moins N; Chezal JM
    Bioorg Med Chem; 2008 Aug; 16(16):7671-90. PubMed ID: 18656367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and preliminary evaluation of the new water-soluble radioactive platinum(IV) complexes.
    Garnuszek P; Maurin M; Skierski JS; Koronkiewicz M; Witowska-Jarosz J
    J Inorg Biochem; 2004 Mar; 98(3):553-9. PubMed ID: 14987857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter.
    Gardette M; Papon J; Bonnet M; Desbois N; Labarre P; Wu TD; Miot-Noirault E; Madelmont JC; Guerquin-Kern JL; Chezal JM; Moins N
    Invest New Drugs; 2011 Dec; 29(6):1253-63. PubMed ID: 20567996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.
    Vivier M; Rapp M; Papon J; Labarre P; Galmier MJ; Sauzière J; Madelmont JC
    J Med Chem; 2008 Feb; 51(4):1043-7. PubMed ID: 18237109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
    Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
    Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
    Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
    Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
    Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
    J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of apoptotic effect of cyclic imide derivatives on murine B16F10 melanoma cells.
    Machado KE; Oliveira KN; Santos-Bubniak L; Licínio MA; Nunes RJ; Santos-Silva MC
    Bioorg Med Chem; 2011 Nov; 19(21):6285-91. PubMed ID: 21964182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
    Bonnet-Duquennoy M; Papon J; Mishellany F; Labarre P; Guerquin-Kern JL; Wu TD; Gardette M; Maublant J; Penault-Llorca F; Miot-Noirault E; Cayre A; Madelmont JC; Chezal JM; Moins N
    Int J Cancer; 2009 Aug; 125(3):708-16. PubMed ID: 19437532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evaluation of two radioiodinated maleimide derivatives targeting peripheral and membrane sulfhydryl groups for in vitro cell labeling.
    Amartey JK; Parhar RS; Shi Y; Al-Mohanna F
    Appl Radiat Isot; 2011 Jan; 69(1):163-70. PubMed ID: 20843697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability.
    Yang P; Yang Q; Qian X; Tong L; Li X
    J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
    Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
    Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two (125)I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma.
    Gardette M; Viallard C; Paillas S; Guerquin-Kern JL; Papon J; Moins N; Labarre P; Desbois N; Wong-Wah-Chung P; Palle S; Wu TD; Pouget JP; Miot-Noirault E; Chezal JM; Degoul F
    Invest New Drugs; 2014 Aug; 32(4):587-97. PubMed ID: 24691673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the synthesis and biological properties of non-carrier-added [(125)I and (131)I]-labeled arylalkylidenebisphosphonates: potent bone-seekers for diagnosis and therapy of malignant osseous lesions.
    Arstad E; Hoff P; Skattebøl L; Skretting A; Breistøl K
    J Med Chem; 2003 Jul; 46(14):3021-32. PubMed ID: 12825941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
    Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS
    Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
    Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
    Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted radiotherapy of pigmented melanoma with
    Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
    Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
    Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.